Literature DB >> 16135528

The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases.

Nadia Nour1, Gaétan Mayer, John S Mort, Alexandre Salvas, Majambu Mbikay, Charlotte J Morrison, Christopher M Overall, Nabil G Seidah.   

Abstract

The proprotein convertases PC5, PACE4 and furin contain a C-terminal cysteine-rich domain (CRD) of unknown function. We demonstrate that the CRD confers to PC5A and PACE4 properties to bind tissue inhibitors of metalloproteinases (TIMPs) and the cell surface. Confocal microscopy and biochemical analyses revealed that the CRD is essential for cell surface tethering of PC5A and PACE4 and that it colocalizes and coimmunoprecipitates with the full-length and C-terminal domain of TIMP-2. Surface-bound PC5A in TIMP-2 null fibroblasts was only observed upon coexpression with TIMP-2. In COS-1 cells, plasma membrane-associated PC5A can be displaced by heparin, suramin, or heparinases I and III and by competition with excess exogenous TIMP-2. Furthermore, PC5A and TIMP-2 are shown to be colocalized over the surface of enterocytes in the mouse duodenum and jejunum, as well as in liver sinusoids. In conclusion, the CRD of PC5A and PACE4 functions as a cell surface anchor favoring the processing of their cognate surface-anchored substrates, including endothelial lipase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16135528      PMCID: PMC1266420          DOI: 10.1091/mbc.e05-06-0504

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  70 in total

1.  The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin alpha5beta1.

Authors:  C Rovère; J Luis; J C Lissitzky; A Basak; J Marvaldi; M Chrétien; N G Seidah
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

2.  Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).

Authors:  S Zucker; M Drews; C Conner; H D Foda; Y A DeClerck; K E Langley; W F Bahou; A J Docherty; J Cao
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

3.  The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study.

Authors:  G S Butler; M J Butler; S J Atkinson; H Will; T Tamura; S Schade van Westrum; T Crabbe; J Clements; M P d'Ortho; G Murphy
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

4.  Alpha1-antitrypsin Portland inhibits processing of precursors mediated by proprotein convertases primarily within the constitutive secretory pathway.

Authors:  S Benjannet; D Savaria; A Laslop; J S Munzer; M Chrétien; M Marcinkiewicz; N G Seidah
Journal:  J Biol Chem       Date:  1997-10-17       Impact factor: 5.157

5.  Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site-directed mutagenesis. The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin modules III and IV.

Authors:  C M Overall; A E King; D K Sam; A D Ong; T T Lau; U M Wallon; Y A DeClerck; J Atherstone
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

6.  Endothelial lipase is inactivated upon cleavage by the members of the proprotein convertase family.

Authors:  Martin Gauster; Andelko Hrzenjak; Katja Schick; Sasa Frank
Journal:  J Lipid Res       Date:  2005-02-01       Impact factor: 5.922

7.  A novel endothelial-derived lipase that modulates HDL metabolism.

Authors:  M Jaye; K J Lynch; J Krawiec; D Marchadier; C Maugeais; K Doan; V South; D Amin; M Perrone; D J Rader
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

8.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol.

Authors:  Suzanne Benjannet; David Rhainds; Rachid Essalmani; Janice Mayne; Louise Wickham; Weijun Jin; Marie-Claude Asselin; Josée Hamelin; Mathilde Varret; Delphine Allard; Mélanie Trillard; Marianne Abifadel; Angie Tebon; Alan D Attie; Daniel J Rader; Catherine Boileau; Louise Brissette; Michel Chrétien; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

10.  alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent.

Authors:  F Jean; K Stella; L Thomas; G Liu; Y Xiang; A J Reason; G Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 12.779

View more
  38 in total

1.  On the cutting edge of proprotein convertase pharmacology: from molecular concepts to clinical applications.

Authors:  Frédéric Couture; François D'Anjou; Robert Day
Journal:  Biomol Concepts       Date:  2011-10-01

2.  The microenvironment patterns the pluripotent mouse epiblast through paracrine Furin and Pace4 proteolytic activities.

Authors:  Daniel Mesnard; Martyn Donnison; Christophe Fuerer; Peter L Pfeffer; Daniel B Constam
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

Review 3.  Insights from bacterial subtilases into the mechanisms of intramolecular chaperone-mediated activation of furin.

Authors:  Ujwal Shinde; Gary Thomas
Journal:  Methods Mol Biol       Date:  2011

4.  RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor.

Authors:  Jeffrey Stein; Rohan Shah; Donald F Steiner; Arunangsu Dey
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

5.  Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A.

Authors:  Xiaowei Sun; Rachid Essalmani; Delia Susan-Resiga; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

6.  Functional analysis of corin protein domains required for PCSK6-mediated activation.

Authors:  Shenghan Chen; Hao Wang; Heng Li; Yue Zhang; Qingyu Wu
Journal:  Int J Biochem Cell Biol       Date:  2017-11-24       Impact factor: 5.085

7.  Opposite roles of furin and PC5A in N-cadherin processing.

Authors:  Deborah Maret; Mohamad Seyed Sadr; Emad Seyed Sadr; David R Colman; Rolando F Del Maestro; Nabil G Seidah
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

8.  Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids.

Authors:  Patricia M Day; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Imaging proprotein convertase activities and their regulation in the implanting mouse blastocyst.

Authors:  Daniel Mesnard; Daniel B Constam
Journal:  J Cell Biol       Date:  2010-09-27       Impact factor: 10.539

10.  The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model.

Authors:  Xiaowei Sun; Rachid Essalmani; Nabil G Seidah; Annik Prat
Journal:  Mol Cancer       Date:  2009-09-08       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.